Rainmed Medical Limited (HKG:2297)

Rainmed Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.78	14.41	54.61	134.09	91.12	559.14
Short-Term Investments	-	-	11.09	65.55	355.2	-
Trading Asset Securities	121.26	138.88	139.85	135.65	132.65	-
Cash & Short-Term Investments	129.04	153.28	205.55	335.28	578.96	559.14
Cash Growth	-35.72%	-25.43%	-38.69%	-42.09%	3.55%	-
Accounts Receivable	0.99	1.31	2.09	3.69	3.68	-
Other Receivables	48.93	38.87	16.4	6.66	6.39	0.38
Receivables	49.91	40.18	18.49	10.35	10.07	0.38
Inventory	16.07	11.35	11.05	9.79	7.61	9.91
Other Current Assets	3.09	2.31	2.83	13.8	6.8	6.22
Total Current Assets	198.11	207.12	237.91	369.22	603.43	575.65
Property, Plant & Equipment	319.26	281.68	150.17	117.65	38.74	43.2
Goodwill	-	-	6.81	12.59	-	-
Other Intangible Assets	3.6	4.05	5.08	41.55	13.1	0.24
Long-Term Deferred Tax Assets	24.63	24.63	24.63	24.63	24.62	19.16
Long-Term Deferred Charges	23.14	27.99	38.11	-	-	-
Other Long-Term Assets	0.02	0.04	0.36	7.67	10.44	1.94
Total Assets	568.76	545.5	463.06	573.31	690.33	640.19

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	28.95	139.02	7.4	4.56	4.36	1.83
Accrued Expenses	13.72	13.9	13.55	24.47	34.87	15.47
Short-Term Debt	-	-	-	-	18	-
Current Portion of Long-Term Debt	23.79	19.69	18.69	3.89	-	-
Current Portion of Leases	0.89	1.04	2.32	4.06	7.4	7.82
Current Income Taxes Payable	-	0	0.03	0.01	-	3.53
Current Unearned Revenue	14.03	9.57	6.36	3.98	3.49	6.73
Other Current Liabilities	-	-	-	-	-	8.69
Total Current Liabilities	81.37	183.24	48.34	40.98	68.12	44.07
Long-Term Debt	157.26	4	3.89	11.68	-	1,362
Long-Term Leases	0.03	0.08	0.69	0.37	3.58	8.86
Long-Term Deferred Tax Liabilities	0.2	0.2	0.23	0.27	-	-
Total Liabilities	238.86	187.51	53.15	53.3	71.69	1,415

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.12	0.12	0.1	0.1	0.1	0
Additional Paid-In Capital	2,819	2,819	2,787	2,787	2,787	-
Retained Earnings	-2,548	-2,526	-2,449	-2,335	-2,220	-873.59
Comprehensive Income & Other	58.84	63.92	68.95	63.51	51.26	86.11
Total Common Equity	330.32	357.39	407	515.05	618.64	-787.48
Minority Interest	-0.42	0.6	2.92	4.96	-	-
Shareholders' Equity	329.9	357.99	409.91	520.01	618.64	-774.48
Total Liabilities & Equity	568.76	545.5	463.06	573.31	690.33	640.19

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	181.97	24.82	25.58	20	28.98	1,378
Net Cash (Debt)	-52.93	128.46	179.97	315.28	549.98	-819.29
Net Cash Growth	-	-28.62%	-42.92%	-42.67%	-	-
Net Cash Per Share	-0.04	0.10	0.15	0.27	0.61	-1.27
Filing Date Shares Outstanding	1,401	1,401	1,168	1,168	1,168	644.52
Total Common Shares Outstanding	1,401	1,401	1,168	1,168	1,168	644.52
Working Capital	116.74	23.89	189.57	328.23	535.31	531.58
Book Value Per Share	0.24	0.26	0.35	0.44	0.53	-1.22
Tangible Book Value	326.72	353.34	395.11	460.91	605.54	-787.73
Tangible Book Value Per Share	0.23	0.25	0.34	0.39	0.52	-1.22
Machinery	19.14	19.15	20.44	20.46	11.33	6.58
Construction In Progress	306.11	264.89	124.31	81.56	2.14	4.78
Leasehold Improvements	38.45	38.45	38.45	38.34	35.05	25.27

Data Source: S&P Global Market Intelligence Last updated: Sep 25, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 7, 2026

Data Sources Report a data error